Price $155.25 |
Market Cap
989.5M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
23.8
|
P/B
4.14
|
P/S
2.78
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
267.9
|
Op. Cash Flow
17.7K
|
FCF
0.4
|
|
Op. Margin
15.60%
|
Net Margin
11.80%
|
ROE
19.20%
|
ROI
15.20%
|
|
ROA
11.00%
|
EPS Growth
161.50%
|
Current Ratio
2.1
|
Debt/Equity
21.60%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Puma Biotechnology Inc (PBYI) | $3.19 | - | - | 133.9M | Strong Buy |
| Bausch Health Companies Inc (BHC) | $8.14 | - | - | 2.78B | Strong Buy |
| Baudax Bio Inc (BXRX) | $0.54 | - | - | 4.4M | Strong Buy |
| Eton Pharmaceuticals Inc (ETON) | $3.86 | - | - | 101.3M | Strong Buy |
| Spero Therapeutics Inc (SPRO) | $1.77 | - | - | 74.6M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
